Morgan Stanley lowered the firm’s price target on UnitedHealth to $584 from $618 and keeps an Overweight rating on the shares. Into the print, the firm expects more questions than answers, with Morgan Stanley saying cost trend concerns and reduced transparency as a result of the Change Healthcare cyberattack drive likely upward pressure on medial loss ratios, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH: